Nurse Practitioner, Gerontology · Woodbridge, VA
NPI
1649817016
Since 2019
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1990 Old Bridge Rd Ste 201
Woodbridge, VA, 22192
Phone (703) 492-6822
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
10,891 services
Medicare patients, 2024
374
Average age 72
Drug cost, 2024
$378K
1,495 prescriptions
Company payments, 2025
$782
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kasheika McNeill was code Q9966 (low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml), 3,750 times for 14 patients. In total Kasheika McNeill billed 10,891 services in 38 codes, and Medicare paid $151K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 3,750 | 14 | $0.30 | $1,110 |
| J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2,210 | 27 | $0.02 | $46.03 |
| J2795 Injection, ropivacaine hydrochloride, 1 mg | Office | 1,850 | 14 | $0.05 | $99.09 |
| 99214 Office E&M - Established | Office | 899 | 180 | $83.77 | $75K |
| J3300 Injection, triamcinolone acetonide, preservative free, 1 mg | Office | 840 | 19 | $5.63 | $4,729 |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 513 | 153 | $54.08 | $28K |
| 99213 Office E&M - Established | Office | 252 | 198 | $60.50 | $15K |
| 97032 PT Treatment | Office | 115 | 17 | $9.28 | $1,067 |
| 96116 Behavioral Health Services | Office | 81 | 75 | $57.10 | $4,625 |
| 93000 Electrocardiogram | Office | 39 | 39 | $9.08 | $354 |
| 95938 Electrical Nerve Conductivity | Office | 34 | 34 | $285.52 | $9,708 |
| 99204 Office E&M - New | Office | 23 | 23 | $101.08 | $2,325 |
| 20610 Joint Injection | Office | 17 | 12 | $45.71 | $777 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 14 | 14 | $117.26 | $1,642 |
| 20553 Musculoskeletal | Office | 14 | 13 | $44.09 | $617 |
By year: 2023 $11K for 786 services; 2024 $151K for 10,891 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kasheika McNeill prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 241 prescriptions and refills. In total Kasheika McNeill wrote 1,495 Medicare prescriptions that cost $378K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 241 | 241 | 63 | $4,491 |
| Diclofenac Sodium Generic | 115 | 115 | 34 | $147K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 96 | 96 | 33 | $2,321 |
| Gabapentin Generic | 89 | 92 | 31 | $614 |
| Oxycodone Hcl Generic | 73 | 73 | 23 | $1,157 |
| Ztlido Lidocaine | 67 | 67 | 23 | $44K |
| Movantik Naloxegol Oxalate | 61 | 61 | 28 | $24K |
| Naloxone Hcl Generic | 53 | 53 | 45 | $3,361 |
| Pregabalin Generic | 47 | 47 | 12 | $376 |
| Xtampza Er Oxycodone Myristate | 37 | 37 | 11 | $13K |
| Tramadol Hcl Generic | 31 | 31 | Under 11 | $110 |
| Morphine Sulfate Er Morphine Sulfate | 30 | 30 | Under 11 | $619 |
| Hysingla Er Hydrocodone Bitartrate | 29 | 29 | Under 11 | $12K |
| Atorvastatin Calcium Generic | 29 | 71 | 11 | $243 |
| Cyclobenzaprine Hcl Generic | 28 | 28 | 11 | $62.77 |
Brand drugs: 358 claims; generic drugs: 1,137 claims; opioid claims: 592.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kasheika McNeill $782 ($782 in general payments such as food, travel and fees) from 13 companies. The largest payer was CVRx, Inc. with $202.
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. CVRX | 3 | $202 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $81.08 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $69.52 |
| Merck Sharp & Dohme LLC MRK | 3 | $66.98 |
| Scpharmaceuticals Inc. SCPH | 2 | $65.71 |
| Novo Nordisk Inc NVO | 2 | $55.61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44.14 |
| Lilly USA, LLC LLY | 2 | $41.8 |
| Boston Scientific Corporation BSX | 2 | $40.94 |
| Kestra Medical Technology Services, Inc. | 1 | $40.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.